logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

HKD interbank rates show mixed developments; one-month rate reverses decline to rise, reported at 2.75%.

date
22/10/2026
Zhitong Finance APP has learned that on October 22, HKD interbank rates showed mixed developments, with the one-month interbank rate related to mortgage loans reported at 2.74500%, up 6.583 basis points; the three-month interbank rate, which reflects banks' funding costs, reported at 3.25405%, down 1.339 basis points.
Latest
4 m ago
SSY Group (02005.HK): Labetalol Hydrochloride Has Been Approved by the National Medical Products Administration for Registration as an API for Use in Marketed Formulations
6 m ago
The "15th Five-Year Plan for Radio, Television and Online Audiovisual" has been issued: accelerate the building of an integrated comprehensive technology platform featuring IP-based, cloud-based, intelligent and integrated development, and promote lightweight production and broadcasting.
7 m ago
The National Radio and Television Administration has issued the "15th Five-Year Plan for Radio, Television, and Online Audiovisual".
7 m ago
Transcenta Holding-B (02617): Jienertai has issued its first clinical prescriptions in multiple provinces, with simultaneous stocking completed at DTP pharmacies in many locations across the country.
10 m ago
Tesla's Monthly Sales in Europe Surge
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.